東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Radiopharmaceutical therapy

Bodei, Lisa.

Linked to FindBook

Google Book

Amazon

博客來

Radiopharmaceutical therapy

Record Type:	Electronic resources : Monograph/item
Title/Author:	Radiopharmaceutical therapy/ edited by Lisa Bodei, Jason S. Lewis, Brian M. Zeglis.
other author:	Bodei, Lisa.
Published:	Cham :Springer International Publishing : : 2023.,
Description:	xi, 564 p. :illustrations, digital ;24 cm.
[NT 15003449]:	Preface -- Foreword -- Section 1. Fundamentals -- Chapter 1. Introduction: The Case for Endoradiotherapy -- Chapter 2. The History of Endoradiotherapy -- Chapter 3. The Nuclear Chemistry of Therapeutic Radionuclides -- Chapter 4. The Production of Therapeutic Radionuclides -- Chapter 5. The Radiobiology of Alpha Particles, Beta Particles, and Auger Electrons -- Chapter 6. The Radiopharmaceutical Chemistry of Metallic Radionuclides -- Chapter 7. The Radiopharmaceutical Chemistry of Non-Metallic Radionuclides -- Chapter 8. Dosimetry in Endoradiotherapy -- Section 2. Deeper Dives -- Chapter 9. Antibodies as Vectors for Endoradiotherapy -- Chapter 10. Case Study #1: 225Ac-Labeled IgG -- Chapter 11. Case Study #2: 131I-3F8 -- Chapter 12. Case Study #3: Antibody Fragments in Endoradiotherapy -- Chapter 13. Peptides as Vectors for Endoradiotherapy -- Chapter 14. Case Study #4: LUTATHERA -- Chapter 15. Case Study #5: CXCR4 -- Chapter 16. Case Study #6: JR11 -- Chapter 17. Small Molecules as Vectors for Endoradiotherapy -- Chapter 18. Case Study #7: PSMA-617 -- Chapter 19. Case Study #8: 223RaCl3 -- Section 3. Special Topics -- Chapter 20. Auger Emitters in Endoradiotherapy -- Chapter 21. In Vivo Pretargeting -- Chapter 22. Theranostic Imaging and Endoradiotherapy -- Chapter 23. The Next Generation of Therapeutic Radionuclides -- Chapter 24. Artificial Intelligence and Machine Learning -- Chapter 25. The Regulatory Review of Radiotherapeutics: USA -- Chapter 26. The Regulatory Review of Radiotherapeutics: Europe -- Chapter 27. The Regulatory Review of Radiotherapeutics: Japan -- Chapter 28. Radiotherapeutics in the Nuclear Pharmacy -- Chapter 29. The Future.
Contained By:	Springer Nature eBook
Subject:	Radiopharmaceuticals - Therapeutic use. -
Online resource:	https://doi.org/10.1007/978-3-031-39005-0
ISBN:	9783031390050

Radiopharmaceutical therapy
Radiopharmaceutical therapy[electronic resource] /edited by Lisa Bodei, Jason S. Lewis, Brian M. Zeglis. - Cham :Springer International Publishing :2023. - xi, 564 p. :illustrations, digital ;24 cm.

Preface -- Foreword -- Section 1. Fundamentals -- Chapter 1. Introduction: The Case for Endoradiotherapy -- Chapter 2. The History of Endoradiotherapy -- Chapter 3. The Nuclear Chemistry of Therapeutic Radionuclides -- Chapter 4. The Production of Therapeutic Radionuclides -- Chapter 5. The Radiobiology of Alpha Particles, Beta Particles, and Auger Electrons -- Chapter 6. The Radiopharmaceutical Chemistry of Metallic Radionuclides -- Chapter 7. The Radiopharmaceutical Chemistry of Non-Metallic Radionuclides -- Chapter 8. Dosimetry in Endoradiotherapy -- Section 2. Deeper Dives -- Chapter 9. Antibodies as Vectors for Endoradiotherapy -- Chapter 10. Case Study #1: 225Ac-Labeled IgG -- Chapter 11. Case Study #2: 131I-3F8 -- Chapter 12. Case Study #3: Antibody Fragments in Endoradiotherapy -- Chapter 13. Peptides as Vectors for Endoradiotherapy -- Chapter 14. Case Study #4: LUTATHERA -- Chapter 15. Case Study #5: CXCR4 -- Chapter 16. Case Study #6: JR11 -- Chapter 17. Small Molecules as Vectors for Endoradiotherapy -- Chapter 18. Case Study #7: PSMA-617 -- Chapter 19. Case Study #8: 223RaCl3 -- Section 3. Special Topics -- Chapter 20. Auger Emitters in Endoradiotherapy -- Chapter 21. In Vivo Pretargeting -- Chapter 22. Theranostic Imaging and Endoradiotherapy -- Chapter 23. The Next Generation of Therapeutic Radionuclides -- Chapter 24. Artificial Intelligence and Machine Learning -- Chapter 25. The Regulatory Review of Radiotherapeutics: USA -- Chapter 26. The Regulatory Review of Radiotherapeutics: Europe -- Chapter 27. The Regulatory Review of Radiotherapeutics: Japan -- Chapter 28. Radiotherapeutics in the Nuclear Pharmacy -- Chapter 29. The Future.

This book covers foundational topics in the emerging field of radiopharmaceutical therapy. It is divided into three sections: fundamentals, deeper dives, and special topics. In the first section, the authors examine the field from a bird's-eye view, covering topics including the history of radiopharmaceutical therapy, the radiobiology of radiopharmaceutical therapy, and the radiopharmaceutical chemistry of both metallic and non-metallic radionuclides. The second section provides a more in-depth look at specific radiotherapeutics. Chapters include broader discussions of the different platforms for radiopharmaceutical therapy as well as more focused case studies covering individual radiotherapeutics. The third and final section explores a number of areas for further study, including medical physics, artificial intelligence, in vivo pretargeting, theranostic imaging, and the regulatory review process for radiotherapeutics. This book is the first of its kind and is useful for a broad audience of scientists, researchers, physicians, and students across a range of fields, including biochemistry, cancer biology, nuclear medicine, radiology, and radiation oncology.

ISBN: 9783031390050

Standard No.: 10.1007/978-3-031-39005-0doiSubjects--Topical Terms:

3609349
Radiopharmaceuticals
--Therapeutic use.

LC Class. No.: RS431.R34

Dewey Class. No.: 615.842

Radiopharmaceutical therapy
LDR:03847nmm a2200325 a 4500 001 2335912
003 DE-He213
005 20231202090328.0
006 m d
007 cr nn 008maaau
008 240402s2023 sz s 0 eng d
020 $a 9783031390050 $q (electronic bk.)
020 $a 9783031390043 $q (paper)
024 7 $a 10.1007/978-3-031-39005-0 $2 doi
035 $a 978-3-031-39005-0
040 $a GP $c GP
041 0 $a eng
050 4 $a RS431.R34
072 7 $a PSB $2 bicssc
072 7 $a SCI007000 $2 bisacsh
072 7 $a PSB $2 thema
082 0 4 $a 615.842 $2 23
090 $a RS431.R34 $b R129 2023
245 0 0 $a Radiopharmaceutical therapy $h [electronic resource] / $c edited by Lisa Bodei, Jason S. Lewis, Brian M. Zeglis.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2023.
300 $a xi, 564 p. : $b illustrations, digital ; $c 24 cm.
505 0 $a Preface -- Foreword -- Section 1. Fundamentals -- Chapter 1. Introduction: The Case for Endoradiotherapy -- Chapter 2. The History of Endoradiotherapy -- Chapter 3. The Nuclear Chemistry of Therapeutic Radionuclides -- Chapter 4. The Production of Therapeutic Radionuclides -- Chapter 5. The Radiobiology of Alpha Particles, Beta Particles, and Auger Electrons -- Chapter 6. The Radiopharmaceutical Chemistry of Metallic Radionuclides -- Chapter 7. The Radiopharmaceutical Chemistry of Non-Metallic Radionuclides -- Chapter 8. Dosimetry in Endoradiotherapy -- Section 2. Deeper Dives -- Chapter 9. Antibodies as Vectors for Endoradiotherapy -- Chapter 10. Case Study #1: 225Ac-Labeled IgG -- Chapter 11. Case Study #2: 131I-3F8 -- Chapter 12. Case Study #3: Antibody Fragments in Endoradiotherapy -- Chapter 13. Peptides as Vectors for Endoradiotherapy -- Chapter 14. Case Study #4: LUTATHERA -- Chapter 15. Case Study #5: CXCR4 -- Chapter 16. Case Study #6: JR11 -- Chapter 17. Small Molecules as Vectors for Endoradiotherapy -- Chapter 18. Case Study #7: PSMA-617 -- Chapter 19. Case Study #8: 223RaCl3 -- Section 3. Special Topics -- Chapter 20. Auger Emitters in Endoradiotherapy -- Chapter 21. In Vivo Pretargeting -- Chapter 22. Theranostic Imaging and Endoradiotherapy -- Chapter 23. The Next Generation of Therapeutic Radionuclides -- Chapter 24. Artificial Intelligence and Machine Learning -- Chapter 25. The Regulatory Review of Radiotherapeutics: USA -- Chapter 26. The Regulatory Review of Radiotherapeutics: Europe -- Chapter 27. The Regulatory Review of Radiotherapeutics: Japan -- Chapter 28. Radiotherapeutics in the Nuclear Pharmacy -- Chapter 29. The Future.
520 $a This book covers foundational topics in the emerging field of radiopharmaceutical therapy. It is divided into three sections: fundamentals, deeper dives, and special topics. In the first section, the authors examine the field from a bird's-eye view, covering topics including the history of radiopharmaceutical therapy, the radiobiology of radiopharmaceutical therapy, and the radiopharmaceutical chemistry of both metallic and non-metallic radionuclides. The second section provides a more in-depth look at specific radiotherapeutics. Chapters include broader discussions of the different platforms for radiopharmaceutical therapy as well as more focused case studies covering individual radiotherapeutics. The third and final section explores a number of areas for further study, including medical physics, artificial intelligence, in vivo pretargeting, theranostic imaging, and the regulatory review process for radiotherapeutics. This book is the first of its kind and is useful for a broad audience of scientists, researchers, physicians, and students across a range of fields, including biochemistry, cancer biology, nuclear medicine, radiology, and radiation oncology.
650 0 $a Radiopharmaceuticals $x Therapeutic use. $3 3609349
650 1 4 $a Biochemistry. $3 518028
650 2 4 $a Cancer Therapy. $3 3594090
650 2 4 $a Radiation Oncology. $3 3593533
650 2 4 $a Cancer Imaging. $3 900314
650 2 4 $a Nuclear Chemistry. $3 894179
700 1 $a Bodei, Lisa. $3 3668662
700 1 $a Lewis, Jason. $3 3668663
700 1 $a Zeglis, Brian Matthew. $3 3668664
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-031-39005-0
950 $a Biomedical and Life Sciences (SpringerNature-11642)